EUVIMEDEUVIMED entdecken
Editorial

Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Authors' Reply

Yu-Sheng Lin, Hwai-I Yang, Teng-Yu Lee iD

Alimentary Pharmacology & Therapeutics · 2026-05 · 63 (10) · 1429-1430

DOI: 10.1111/apt.70628 ↗

Kurz gefasst

Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 17.03.2026. Verfasst von Yu-Sheng Lin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

genetic risk scorehepatitis Chepatocellular carcinoma

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

ORCID-Profile: Teng-Yu Lee

Zitieren

APA

Lin, Y. S., Yang, H. I., & Lee, T. Y. (2026). Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Authors' Reply. Alimentary Pharmacology & Therapeutics, 63(10), 1429-1430. https://doi.org/10.1111/apt.70628

Vancouver

Lin YS, Yang HI, Lee TY. Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;63(10):1429-1430. doi:10.1111/apt.70628

BibTeX
@article{Lin2026,
  author = {Lin, Yu-Sheng and Yang, Hwai-I and Lee, Teng-Yu},
  title = {Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {10},
  pages = {1429--1430},
  doi = {10.1111/apt.70628}
}
Kostenlos starten →